The Visualization of Uncertainty in Clinical Diagnostic Reasoning for Pulmonary Embolism

Sponsor
University of Calgary (Other)
Overall Status
Completed
CT.gov ID
NCT01752673
Collaborator
(none)
30
1
2
7
4.3

Study Details

Study Description

Brief Summary

Medical reasoning is a form of inquiry that examines the thought processes involved in making medical decisions. When physicians are faced with patients' symptoms or signs, their thought processes follow either direct shortcuts to suspect a diagnosis or go into a deeper and more analytic process to reach a diagnosis. The second pathway is less prone to biases and errors. This study explores whether the use of an interactive visual display of probabilities of pulmonary embolism generated from positive or negative test results will increase the adherence to evidence based guidelines in the diagnosis of pulmonary embolism.

Condition or Disease Intervention/Treatment Phase
  • Other: Visualized pulmonary embolism computer task model
  • Other: Didactic review lecture
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
The Visualization of Uncertainty in Clinical Diagnostic Reasoning for Pulmonary Embolism: a Randomized Controlled Trial.
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Oct 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Visualized pulmonary embolism computer task model

This group of participants was presented and trained to use a visual representation of diagnostic pathway for pulmonary embolism. The design of this visual representation is based on Bayes theorem and cognition enhancing visual design principles.

Other: Visualized pulmonary embolism computer task model
This group of participants was presented and trained to use a visual representation of diagnostic pathway for pulmonary embolism. The design of this visual representation is based on Bayes theorem and cognition enhancing visual design principles.

Active Comparator: Didactic review pulmonary embolism lecture

This group of participants was presented with a didactic lecture covering the diagnostic approach of pulmonary embolism.

Other: Didactic review lecture
This group of participants was presented with a didactic lecture covering the diagnostic approach of pulmonary embolism.

Outcome Measures

Primary Outcome Measures

  1. Concordance with medical diagnostic reasoning pathway for pulmonary embolism. [Paper-based clinical case scenarios were completed within 2 hour after either intervention.]

    Concordance with medical diagnostic reasoning pathway for a case presentation suggestive of pulmonary embolism will be reflected by whether participants are stopping prematurely or proceeding with diagnostic steps inappropriately.

Secondary Outcome Measures

  1. Time. [Paper-based clinical case scenarios were completed within 2 hour after either intervention.]

    The overall time taken to solve each clinical scenario may give insight to which decision making process was predominant to solve each clinical scenario.

Other Outcome Measures

  1. Survey. [Survey was completed within 2 hours after completion of either intervention.]

    The participants' responses to the satisfaction survey will provide feedback about the need for improvement or modification in interface of software

Eligibility Criteria

Criteria

Ages Eligible for Study:
24 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Medical students, University of Calgary, in clerkship who finished at least 4 weeks of a block of medicine rotation at any hospital site.

  • First year subspecialty or Internal Medicine residents.

  • Practicing physicians in the subspecialties of Internal Medicine or Emergency Medicine.

Exclusion Criteria:
  • Physicians in the subspecialty of Haematology or Respiratory

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Calgary Calgary Alberta Canada T2V1P9

Sponsors and Collaborators

  • University of Calgary

Investigators

  • Principal Investigator: Ghazwan Altabbaa, MD MSc, University of Calgary

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ghazwan Altabbaa, Doctor, University of Calgary
ClinicalTrials.gov Identifier:
NCT01752673
Other Study ID Numbers:
  • 23231
First Posted:
Dec 19, 2012
Last Update Posted:
Dec 19, 2012
Last Verified:
Dec 1, 2012
Keywords provided by Ghazwan Altabbaa, Doctor, University of Calgary
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 19, 2012